WITTEVEEN-KOLK SYNDROME
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A catalog of genetic loci associated with kidney function from analyses of a million individuals.
|
31152163 |
2019 |
Downward slant of palpebral fissure
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Small hand
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Autistic behavior
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Long face
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Depressed nasal bridge
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Poor school performance
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Clinodactyly of the 5th finger
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Thick ear helices
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
SIGNIFICANCE: This study delineates the transcriptional regulatory complex Sin3A as a mediator of STAT3 transcriptional repressor activity and identifies the STAT3/Sin3A axis as a druggable target to antagonize STAT3-addicted tumors.
|
30692217 |
2019 |
Non-Small Cell Lung Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
It was observed that miR-210-3p was significantly upregulated in NSCLC tissues compared with the levels in the adjacent normal tissues, and that the expression of miR-210-3p in patients with NSCLC was negatively correlated with the expression of SIN3A in NSCLC tissue. miR-210-3p was also significantly upregulated in different NSCLC cell lines compared with the levels in BEAS-2B cells.
|
31555365 |
2019 |
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
|
31365169 |
2019 |
Central neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
|
31365169 |
2019 |
Childhood Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
|
31365169 |
2019 |
High-Risk Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We showed that ARID1A directly caused suppression of TERT and was reliant on DNA binding and co-occupancy of the TERT promoter by the SIN3 transcription regulator family member A (SIN3A) repressor complex allowing NB differentiation to proceed.
|
31365169 |
2019 |
Malignant neoplasm of breast
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
These observations reveal that the SIN3A mutation has lost its transcriptional repression function due to its cytoplasmic localization, and that this repression may contribute to the progression of breast cancer.
|
30375428 |
2018 |
Malignant neoplasm of breast
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our data indicate that LSD1 is a functional alternative subunit of the SIN3A/HDAC complex, providing a molecular basis for the interplay of histone demethylation and deacetylation in chromatin remodelling, and suggest that the LSD1/SIN3A/HDAC complex could be a target for breast cancer therapeutic strategies.
|
29741645 |
2018 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
In tissue sections from the breast cancer patient with the SIN3A c.2830 C>T mutation, cytoplasmic SIN3A localization was detected within the tumor regions where nuclear enlargement was observed.
|
30375428 |
2018 |
Breast Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our data indicate that LSD1 is a functional alternative subunit of the SIN3A/HDAC complex, providing a molecular basis for the interplay of histone demethylation and deacetylation in chromatin remodelling, and suggest that the LSD1/SIN3A/HDAC complex could be a target for breast cancer therapeutic strategies.
|
29741645 |
2018 |
Breast Carcinoma
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
These observations reveal that the SIN3A mutation has lost its transcriptional repression function due to its cytoplasmic localization, and that this repression may contribute to the progression of breast cancer.
|
30375428 |
2018 |
Triple Negative Breast Neoplasms
|
0.040 |
Biomarker
|
disease |
BEFREE |
We next show that BCL11A(2-16) pulls down RBBP4, RBBP7, and other components of PRC2, NuRD, and SIN3A from the cell lysate of the TNBC cell line SUM149.
|
29263092 |
2018 |
Triple-Negative Breast Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
We next show that BCL11A(2-16) pulls down RBBP4, RBBP7, and other components of PRC2, NuRD, and SIN3A from the cell lysate of the TNBC cell line SUM149.
|
29263092 |
2018 |
Leukemia, Myelocytic, Acute
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Notably, SIN3A expression shows prognostic value in AML.
|
29764005 |
2018 |
Amnesia
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study examines the role of co-repressor SIN3A in scopolamine-induced amnesia through epigenetic changes in the hippocampus.
|
29494759 |
2018 |